RecruitingNCT06148779

Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care

Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care in Urban and Rural Areas of Sweden

Sponsor

Joint Academy

Enrollment

50,000 participants

Start Date

Jan 1, 2022

Study Type

OBSERVATIONAL

Conditions

First-line Treatment Osteoarthritis Health Services Accessibility

Summary

To improve chronically ill patients' health and quality of life, long-standing and continuous treatment is needed at an acceptable cost. The purpose of this study was to compare utilization of digital versus face-to-face delivered osteoarthritis (OA) treatment in the 21 different county councils of Sweden that are responsible for providing healthcare to the residents.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Digitally delivered first-line treatment for osteoarthritis and a behavioral approach called Face-to-face first-line treatment for osteoarthritis for people with first-line treatment, health services accessibility, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALDigitally delivered first-line treatment for osteoarthritis

Digitally delivered first-line for osteoarthritis through the caregiver Joint Academy.

BEHAVIORALFace-to-face first-line treatment for osteoarthritis

First-line for osteoarthritis delivered at a primary care clinic face-to-face with reported data to the BOA registry.

Locations(1)

Joint Academy

Malmö, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06148779

Related Trials

Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer

NCT075002981 location

Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1)

NCT069073421 location

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

NCT0715347195 locations

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

NCT07353931161 locations

Genicular Artery Embolization for Knee Osteoarthritis

NCT075371531 location